Revvity Inc. $RVTY Stock Position Lifted by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co grew its position in Revvity Inc. (NYSE:RVTY) by 46.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,199 shares of the company’s stock after acquiring an additional 6,066 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Revvity were worth $1,683,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new stake in Revvity during the second quarter valued at $32,000. MUFG Securities EMEA plc bought a new position in shares of Revvity during the second quarter worth about $34,000. Headlands Technologies LLC acquired a new stake in shares of Revvity in the 2nd quarter worth about $49,000. Smartleaf Asset Management LLC increased its holdings in shares of Revvity by 56.8% in the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after acquiring an additional 250 shares during the period. Finally, Quent Capital LLC bought a new stake in Revvity in the 3rd quarter valued at about $71,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Price Performance

NYSE RVTY opened at $98.49 on Thursday. Revvity Inc. has a 1 year low of $81.36 and a 1 year high of $120.39. The business’s fifty day moving average is $103.27 and its two-hundred day moving average is $96.60. The stock has a market capitalization of $11.01 billion, a P/E ratio of 47.35, a P/E/G ratio of 2.04 and a beta of 1.10. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.15. The business had revenue of $772.06 million during the quarter, compared to analyst estimates of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The company’s revenue was up 5.9% compared to the same quarter last year. During the same period last year, the company posted $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, research analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 13.46%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Bank of America cut shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a research report on Monday, December 15th. Wells Fargo & Company increased their price objective on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 3rd. JPMorgan Chase & Co. raised their target price on Revvity from $100.00 to $105.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, February 26th. Finally, Barclays increased their price target on Revvity from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 3rd. Five equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $113.67.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.